|
ERP
and SCM Solutions to Offer Effective Means to Streamline European
Pharmaceutical Distribution Channels
LONDON, United Kingdom — November 15, 2006 — The increasing need to
prevent sales of counterfeit medicines and avoid stock outs of drugs has
created a compelling need for effective IT solutions to rationalise
pharmaceutical distribution channels across Europe. With comprehensive
support from information technology (IT) across distribution channels,
the European pharmaceutical industry will experience robust growth.
In
particular, enterprise resource planning (ERP) and supply chain
management (SCM) solutions are projected to penetrate untapped markets
and build complete links between the distributors. ERP and SCM solutions
will enable the operations of various participants in the pharmaceutical
distribution channel to be streamlined, thereby ensuring the prompt and
safe delivery of medicines.
Frost & Sullivan (http://www.healthcare.frost.com) finds that among
Solutions Supporting Pharmaceutical Distribution Channel in
Europe
, ERP and SCM solutions will together earn
revenues of $1,188 million in 2006 and is estimated to reach $1,835
million in 2013, as the market potential for these applications is high
in the European pharmaceutical sector.
“With these IT solutions, manufacturers and other participants in the
distribution channel can track the flow of drugs from pharmacy shelves
and replenish accordingly to avoid stock outs,” says Frost &
Sullivan Research Analyst Rahul Philip Mampallil. “Moreover, companies
can monitor the movement of stocks and detect the illegal intrusion of
batches into the distribution channel.”
While undoubtedly beneficial, the implementation of these supply chain
solutions should meet particular business needs of companies. At the
same time, they should allow easy integration across various functional
areas.
“The challenge here is that solutions provided by various ERP vendors
might have certain modules that do not involve business requirements of
organisations for which they are intended,” says Mr. Mampallil. “The
implementation of an add-on ERP module without understanding specific
business compulsions would constitute an imprudent and reckless
investment.”
Close partnerships between manufacturing companies and IT solution
vendors would enable the latter to suitably assess the company’s
business processes and identify the functional areas that require ERP or
SCM solutions.
If you are interested in a virtual brochure, which provides
manufacturers, end users, and other industry participants with an
overview of the latest analysis of the Solutions Supporting
Pharmaceutical Distribution Channel in Europe (M023 – 48) then send an
e-mail to Radhika Menon Theodore - Corporate Communications at
rmtheodore@frost.com with the following information: your full name,
company name, title, telephone number, e-mail address, city, state, and
country. We will send you the information via email upon receipt of the
above information.
Solutions Supporting Pharmaceutical Distribution Channel in
Europe
is part of the Healthcare IT Subscription,
which also includes research in the following markets: clinical decision
support systems markets in
Europe
, European patient e-booking systems markets
and healthcare applications of smart cards in
Europe
. All research included in subscriptions
provide detailed market opportunities and industry trends that have been
evaluated following extensive interviews with market participants.
Interviews with the press are available.
Frost & Sullivan, a global growth consulting company, has been
partnering with clients to support the development of innovative
strategies for more than 40 years. The company's industry expertise
integrates growth consulting, growth partnership services, and corporate
management training to identify and develop opportunities. Frost &
Sullivan serves an extensive clientele that includes Global 1000
companies, emerging companies, and the investment community by providing
comprehensive industry coverage that reflects a unique global
perspective and combines ongoing analysis of markets, technologies,
econometrics, and demographics. For more information, visit
www.frost.com
(17/11/06)
|
